Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 28, 2013; 19(28): 4495-4503
Published online Jul 28, 2013. doi: 10.3748/wjg.v19.i28.4495
Published online Jul 28, 2013. doi: 10.3748/wjg.v19.i28.4495
Figure 2 Silencing of basic transcription factor 3 using small interfering RNA.
A: Transfection rates of small interfering RNA (siRNA)-normal control (NC)/siRNA-basic transcription factor 3 (BTF3)-green fluorescent protein (GFP) vectors in human SGC7901 cells, estimated by bright field and fluorescence microscope; B: Bar charts represent quantitative real-time polymerase chain reaction data of BTF3 mRNA levels in control and BTF3-siRNA transfected SGC7901 cells (bP < 0.01 between groups, unpaired t test); C: Immuno-blotting analysis using BTF3-specific antibodies to detect BTF3 protein expressions in control and BTF3-siRNA transfected SGC7901 cells. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as internal control.
- Citation: Liu Q, Zhou JP, Li B, Huang ZC, Dong HY, Li GY, Zhou K, Nie SL. Basic transcription factor 3 is involved in gastric cancer development and progression. World J Gastroenterol 2013; 19(28): 4495-4503
- URL: https://www.wjgnet.com/1007-9327/full/v19/i28/4495.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i28.4495